Pillstats
Rx only · Ointment · Ophthalmic

Neomycin And Polymyxin B Sulfates And Dexamethasone

Dexamethasone + Neomycin Sulfate + Polymyxin B Sulfate

5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
5 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)8536
US makers5 labelers
Packages5
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.833$1.67$2.50$3.33Dec 2025Apr 2026Jul 2026
$2.715
Latest avg · Jul 22, 2026
-6%
Since Dec 17, 2025
5
Active US suppliers
40%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8.1K16K24K32K2025 Q12025 Q22025 Q32025 Q42026 Q1
22K
Rx · 2026 Q1
78K
Units dispensed
-21%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it5 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
ADVANCED RX PHARMACY OF TENNESSEE, LLCunknown1SUPPLYING
Proficient Rx LPunknown1SUPPLYING
Sandoz Incunknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 13, 2022
    RECALLRecall (Class II): Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, 3.5 g tube, Rx only MFG: Sandoz, NDC 61314-631…

    cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.